Earnings Call · Q1 FY2022·2022-05-10

Q1 22EPS +14.63%·Rev n/aQ4 21EPS -29.73%·Rev n/aQ3 21EPS +18.18%·Rev n/aQ2 21EPS -4.08%·Rev n/a⚠ consensus missing

Xenon Pharmaceuticals Inc. XENE

Sherry Aulin — Chief Financial Officer

Ian Mortimer — President and Chief Executive Officer

Chris Kenney — Chief Medical Officer

−5.7%1d on move date−4.1% vs SPY3d+4.2%5d+8.1%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more XENE calls or request research access.

More XENE calls Browse calls Request research access